Leapcure

Antidote is a clinical trial recruitment platform that accelerates medical research by uniting patients and sponsors through precision recruitment services and an intuitive match search engine. By tackling the fact that over 80% of trials are delayed for want of participants, Antidote offers sponsors a vendor-agnostic, centralized dashboard that standardizes referrals from any partner, automates due diligence outreach and owner letters, tracks real-time enrollment and ROI metrics, and delivers actionable site and candidate insights via hourly-updated analytics. For patients, Antidote’s smart match engine transforms complex inclusion and exclusion criteria into simple, guided question-and-answer flows, then presents up-to-date clinical trial listings and personalized alerts when new matches appear. It supports bulk or single-record imports with automated validations and provides multilingual, mobile-friendly interfaces.

Thousands of organizations around the world trust IQVIA to speed drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access to and delivery of healthcare, and ultimately drive better health outcomes. Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster. With a foundation in data, advanced analytics, and expert insight, IQVIA brings specialized capabilities to customers across the healthcare ecosystem. Read and watch the latest from IQVIA data scientists, doctors, researchers, and other subject matter experts on the topics that matter to you. From industry trends to how we are applying our capabilities to help, you can find it here.